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Abstract
Background: Performing clinical research among pediatric end-stage renal disease patients is challenging. Barriers
to successful initiation and completion of clinical research projects include small sample sizes and resultant limited
statistical power and lack of longitudinal follow-up for hard clinical end-points in most single center studies.
Description: Existing longitudinal organ failure disease registry and administrative health datasets available within
a universal access health care system can be used to study outcomes of end-stage renal disease among pediatric
patients in Canada. To construct the Canadian Pediatric End-Stage Renal Disease database, registry data were
linked to administrative health data through deterministic linkage techniques creating a research database which
consists of socio-demographic variables, clinical variables, all-cause hospitalizations, and relevant outcomes (death
and renal allograft loss) for this patient population. The research database also allows study of major cardiovascular
events using previously validated administrative data definitions.
Conclusion: Organ failure registry linked to health administrative data can be a powerful tool to perform
longitudinal studies in pediatric end-stage renal disease patients. The rich clinical and demographic information
found in this database will facilitate study of important medical and non-medical risk factors for death, graft loss
and cardiovascular disease among pediatric end-stage renal disease patients.
Background
End-stage renal disease (ESRD) is rare in childhood.
ESRD incidence rates in children range from 6.9 to 21.8
per million age related population in the 0-4 year old
age group and 15-19 year old age group respectively [1].
As a result, individual pediatric nephrology centers have
a limited number of patients receiving renal replacement
therapy at any given time. Therefore, it is challenging
for single centers to recruit sufficient numbers of
patients to perform adequately powered clinical studies
to evaluate treatment and outcomes in this patient
population. More importantly, outcomes such as death
and major cardiovascular events which require longitu-
dinal follow-up over long periods of time are rarely
documented within pediatric centers, because pediatric
ESRD patients have usually been transferred to adult
oriented care centers before these outcomes occur [2].
Multi-center longitudinal studies for evaluation of
treatments and outcomes among pediatric ESRD
patients are needed to overcome chronic challenges of
inadequate power and lack of longitudinal follow-up.
However, multi-center studies are costly, time consum-
ing and not immediately feasible for many researchers
in the field. Fortunately, there are several well estab-
lished national and international registries documenting
the course and outcomes of both adult and pediatric
ESRD patients [3,4]. These include the United States
Renal Data System (USRDS), [5] the United Network
for Organ Sharing (UNOS),[6] the European Collabora-
tive Transplant Study,[7] European Society of Pediatric
Nephrology/European Renal Association-European Dia-
lysis and Transplant Association, [8,9] and the Australia
and New Zealand Dialysis and Transplant Registry [10].
Data from the Australia and New Zealand registry pro-
vided important information regarding long-term survi-
val in pediatric ESRD patients [4]. There is also a well
established pediatric dialysis and transplant registry, the
North American Pediatric Renal Trials and
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source of important pediatric outcomes data [11]. The
most significant limitation of NAPRTCS is that patients
have no further follow-up after age 21. In Canada, a
well established organ failure registry (Canadian Organ
Replacement Registry) has been collecting information
on almost every single organ donation and transplant in
Canada since 1981[1]. However, this registry has not
been fully utilized to evaluate outcomes among Cana-
dian pediatric ESRD patients.
Administrative databases used to collect data from
Canada’s single payer universal access healthcare system
present a unique opportunity to study pediatric ESRD
patients. Large national administrative health datasets
document hospitalizations, outpatient encounters and
emergency room visits for users of the health system
[1]. Canadian hospital discharge data are routinely
audited and the accuracy of data is greater than 95%
[12]. Such databases have been used widely in Canada
to develop surveillance programs and link processes to
outcomes for various diseases [13-15]. Increasingly,
administrative data are also being used to study diseases
in childhood including asthma and inflammatory bowel
disease [16-18].
This paper describes the creation of the Canadian
Pediatric End-Stage Renal Disease database, a new data-
base formed by combining administrative data from
multiple sources to generate a large and rich, longitudi-
nal dataset of Canadian pediatric ESRD patients. This
new dataset will allow us to study long-term outcomes
(death, allograft loss and major cardiovascular events)
and risk factors for those outcomes in pediatric ESRD
patients.
Construction And Content
Data sources
The Canadian Organ Replacement Register (CORR) is
the sole national organ failure registry in Canada and is
maintained by the Canadian Institute for Health Infor-
mation [1]. All pediatric and adult dialysis and trans-
plant centers in Canada submit data regularly to CORR
using standardized paper forms. CORR data elements
include demographics (age, date of birth, gender, perso-
nal health information number, ethnicity, postal code of
residence), ESRD treatment modalities, change in treat-
ment modalities with dates, treatment facility informa-
tion, renal transplant details, selected comorbidities and
outcomes (death, allograft loss). Height and weight at
time of initiation of renal replacement are also recorded
in the registry. Individual patient data is updated every 6
months.
The registry data have been used extensively in multi-
ple clinical studies in patients with kidney failure
[3,19-25]. A data quality study on the Canadian Organ
Replacement Register was published in July 2009 [26].
This study involved a chart review for a sample of 1351
patient charts to assess documentation and coding prac-
tices at dialysis clinics, and the participation rate in
CORR. In addition, CORR data were compared with
data available in the national hospitalization database
Canadian Institute for Health Information Discharge
Abstract Database (CIHI DAD). It was determined that
CORR captures 98.5% of renal transplants performed in
Canada. Patient demographics were found to be coded
with high reliability in CORR. In contrast, co-morbid-
ities were recorded in CORR with low to moderate
sensitivity, indicating a tendency to under-report co-
morbidities to CORR. Nevertheless, co-morbidities were
recorded with high specificity. The agreement rate
between CORR data and chart review data on the
primary renal disease code was 59%, indicating that
primary renal disease could be more accurately reported
to CORR.
The CIHI DAD is the national Canadian in-patient
discharge abstract database containing demographic,
clinical and institutional data [1]. Hospital discharge
diagnoses are coded using International Statistical
Classification of Diseases and Related Health Problems
9
th and 10
th revisions. In-hospital deaths and dates of
death are also recorded. Each hospital discharge
abstract record contains key demographic variables
(date of birth, gender), personal health number
assigned by relevant health authority, dates of admis-
sion, dates of discharge, up to 16 discharge diagnoses
codes (most responsible diagnosis, pre- and post-
admission co-morbidities) and up to 10 intervention
codes. Special care unit length of stay is also documen-
ted. This dataset is available from the Canadian Insti-
tute for Health Information (CIHI) starting from fiscal
year 1992 and data can be released to investigators
with appropriate ethics approval and safeguards for
privacy.
Linked Data
Ethical approval was obtained from the University of
Calgary to perform data linkages.
The CORR database was used to identify a cohort of
incident pediatric ESRD patients in Canada except for
the Province of Quebec (0-21 years) for the years 1992-
2007. The Province of Quebec has separate privacy leg-
islation and application for data release has been
submitted.
Each patient identified in the registry was linked to
their relevant hospital admissions in CIHI DAD using
deterministic linkage methods. Deterministic linkage is
accomplished by comparing identifying data fields
data from two data sets leading to a judgment on
whether two records refer to the same patient [27].
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creation of this database consisted of only personal
health card number and an exact match of health card
number between two datasets was required to match a
CORR registrant to corresponding hospitalization
records in CIHI DAD [27]. Personal health informa-
tion numbers are assigned by provincial health autho-
rities and edit checks are performed during CORR
data entry process. Personal health card numbers
recorded in CORR are validated for length and alpha
numeric characters and a check sum is computed for
each health card number to detect accidental errors
that may occur during data entry. CIHI DAD data has
similar checking mechanisms to ensure the accuracy
of health card numbers.
Linkage was performed by personnel within CIHI to
comply with privacy legislation. After linkage, each
patient was assigned a unique identification number and
the dataset was stripped of all personal identifying infor-
mation. The merged database (Canadian Pediatric
End-Stage Renal Disease Database) therefore com-
prises linked registry information and hospitalization
records as shown in Figure 1. Selected variables and
outcomes available in the database are shown in tables 1
and 2. The database is arranged longitudinally in time
and includes key clinical information (index renal repla-
cement therapy date, modality and changes in modalities
of renal replacement, date of first transplant, clinical
details of transplant, facilities of ESRD care, renal allo-
graft loss dates and cause of renal allograft loss, hospita-
lizations, death date, cause of death).
Addition of Socioeconomic and Geographic Variables
The merged research database was supplemented with
the addition of two key variables: a measure of socioeco-
nomic status and geography for each patient. The six
digit postal code for each study subject was obtained
from CORR and linked to data from the 2006 Canadian
Census using the Postal Code Conversion File (PCCF)
to determine median neighborhood income quintile as
one measure of socioeconomic status for each patient.
PCCF changes with each census and socioeconomic
Figure 1 Linkage of registry and administrative health data to create Canadian Pediatric End-Stage Renal Disease Database.
Abbreviations - RRT: renal replacement therapy; ICD 9/10: International Statistical Classification of Diseases (ICD-9-CM and ICD-10-CA)
Table 1 Variables available in Canadian Pediatric End-
Stage Renal Disease Database
Sociodemographic variables
Gender
Date of Birth
Race
Region of Residence
Urban or Rural Residence
Neighborhood income quintile
Distance to nearest ESRD* care centers
Selected Clinical variables
Renal replacement therapy start date
First modality of renal replacement
Etiology of renal failure
Dates of change in renal replacement modality
Renal transplant dates
Donor type for transplant
*ESRD: end-stage renal disease
Samuel et al. BMC Nephrology 2010, 11:21
http://www.biomedcentral.com/1471-2369/11/21
Page 3 of 6variables are updated with time. The latest available
PCCF was from year 2006. Residence location was
defined as the distance between the residence of each
patient and the nearest ESRD care centres. For these
distance calculations, a comprehensive dictionary of
postal codes for all Canadian ESRD care centres includ-
ing satellite dialysis centres was created. Then, geo-
graphic coordinates for the center of the polygon
defined by each 6 digit postal code (of patient residence
and ESRD care centres) was determined using the PCCF
and Canadian Postal Data Software (MelissaData, CA).
These coordinates were then entered into ArcGIS 9
software (ESRI, CA) to determine the shortest distance
by road between patient residence and nearest ESRD
care centers. Using average posted speed, estimated tra-
vel times for individual patients to their nearest dialysis
or transplant facilities were also calculated. Furthermore,
we classified each patient residence location as urban or
rural also using the PCCF available through Statistics
Canada [28]. Investigators on this team have prior
experience using these measures of socioeconomic sta-
tus and residence location in studies involving the adult
chronic kidney disease population [20,22,24,25].
Utility
There were 1365 incident end-stage renal disease
patients age ≤ 21 years (excluding province of Quebec)
identified in the registry for the interval between 1992
and 2007, and 1200 (88%) health card numbers were
available for linkage. Among these, 1011 (74.1%) were
linked to CIHI DAD for at least one hospitalization epi-
sode. There were 9908 hospitalization records for the
period 1994-2007 for matched patients (1992-1993 data
was unavailable for linkage). We also performed an
audit of death dates recorded in CORR using available
in-hospital death dates. Of all deaths recorded in the
database, 25% were in-hospital deaths, and were found
in a hospitalization record. Among the in-hospital
deaths, 95% of these were also found in CORR data
with identical death dates for all except one date.
Discussion
The research database described herein represents a
major advance for clinical pediatric nephrology research.
It is a rich source of information containing essential
socio-demographic, clinical and health outcome vari-
ables that will facilitate longitudinal studies in a large
and unselected cohort of pediatric ESRD patients.
Beyond description of long-term patient and allograft
outcomes, the future potential for such a research
database includes assessment of medical risk factors,
non-medical risk factors for various outcomes and quan-
tification of health service utilization (in-patient only) in
t h ee n t i r ec o h o r to fC a n a d i a n pediatric ESRD patients.
The research model can serve as a prototype for other
countries with similar data availability, and provides an
efficient and relatively inexpensive means of studying
very long term outcomes in patients with an uncommon
condition. The database may also facilitate international
comparisons using similar data from other countries.
The single-payer, universal access health care system
in Canada results in important advantages with respect
to this type of database. This system ensures that all
patients will have accessible administrative data files.
This differs from the USRDS, in which administrative
data are only available for patients covered under Medi-
care. Since transplant recipients currently lose Medicare
eligibility after 3 years of graft function, administrative
records are cut off three years after transplant for a sig-
nificant proportion of transplant recipients in the
USRDS [5]. The other major American database, the
United Network for Organ Sharing, is a longitudinal
database of American transplant recipients[6]. Although
it contains information on virtually all transplant recipi-
ents in the US, contribution of follow-up data is not
assured, because only UNOS member centers are
obliged to submit data. Patients transferred to non-
UNOS centers or to private physicians for long term
transplant care will be lost to UNOS. Although UNOS
data can be linked to USRDS administrative data,
administrative records will only exist for patients cov-
ered under Medicare. These problems will not exist in
the single-payer Canadian system.
Using routine demographic information collected, eva-
luation of potential disparities in access to kidney trans-
plantation and time spent on dialysis among vulnerable
sub-populations such as Aboriginal People will be
immediately feasible with this dataset. The relative
importance of socioeconomic status, which is a key
determinant of health and wellbeing, can also be
assessed for its contribution to patient and renal allo-
graft outcomes and access to kidney transplantation.
Equitable access to healthcare irrespective of ethnicity,
gender and socioeconomic status is one of the central
tenets of the Canadian universal access health care sys-
tem. Therefore, the creation of this research database is
a first step in examining ‘at risk’ pediatric populations
for differences in kidney disease care received, and it
Table 2 Outcome variables in Canadian Pediatric
End-Stage Renal Disease Database
Death and Cause of death
Lost to follow-up
Withdrawn from treatment (presumed death)
Renal Allograft loss and cause of allograft loss
Hospitalizations including special care unit admission
Major cardiovascular events
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implementation of changes in health care delivery to
optimize outcomes.
Geographical factors may play important roles in
determining modality of renal replacement and patient
outcomes among Canadian pediatric ESRD patients. To
date, there are no studies examining the role of geogra-
phy on pediatric patient outcomes. Canada has the sec-
ond largest land mass for any country in the world and
it has 11 pediatric ESRD care centers located only in
major cities. Children living in rural remote areas need
to travel long distances by road or air to their nearest
pediatric ESRD care centre, and (since there may be no
hemodialysis unit nearby) peritoneal dialysis may be the
only option for those needing to start dialysis.
This approach will overcome some of the discontinu-
ity in medical records that occurs when a pediatric
patient is transferred to an adult center, effectively
removing the boundaries on length of follow-up
imposed by other registries such as the NAPRTCS;
within the Canadian Pediatric End-Stage Renal Disease
Database each patient can be followed until death if
they reside in the country. This opens the door to stu-
dies examining outcomes occurring during the transi-
tion from pediatric to adult-oriented care - an interval
considered to be at high risk for adverse outcomes
[29,30]. For example, rates of renal allograft loss were
examined during the transition period to adulthood
using linked data from clinical records and administra-
tive health datasets for a single center cohort of pedia-
tric renal transplant patients from Ontario, Canada [31].
In addition to deaths, this database will capture major
cardiovascular events (myocardial infarction, stroke,
congestive heart failure) resulting in, or occurring dur-
ing a hospitalization [32,33]. Cardiovascular end-points
are usually not observed in childhood. A previous study
linked data from medical charts to in-patient hospitali-
zation records, and documented the incidence of major
cardiovascular outcomes in a cohort of pediatric patients
with end-stage renal disease [34]. However, this cohort
was drawn from a single center and did not have access
to full organ failure registry data - a limitation that the
current dataset will overcome.
Although the potential for this research database is
large, there are important limitations to consider. The
use of registry and administrative data limits our ability
to collect key clinical variables such as glomerular filtra-
tion rate and proteinuria which may influence patient
and renal allograft outcomes. CORR data collection
forms do not include these clinical variables; however,
there is potential in the future to link to laboratory data-
bases to obtain this information in certain jurisdictions.
Registry data is submitted voluntarily by each center
using paper based forms and potential for under-
reporting exists. In terms of residence location, the postal
codes are recorded on entry into CORR and we cannot
capture residence moves presently. We are also unable to
capture hospitalizations in other countries if patients tra-
vel abroad, although the likelihood of out-country hospi-
talizations occurring is negligible in this population.
Determination of the cause of death from registry data is
potentially problematic. Previous studies indicate that
agreement between death certificates and data from dia-
lysis registries is poor - perhaps because “kidney failure”
is often listed as the cause of death on the former, or
because many patients die at home (where cause of death
cannot readily be ascertained) [35,36]. Currently, it is not
feasible to obtain outpatient physician and emergency
room encounters and therefore, the dataset is limited to
inpatient encounters only. Finally, this dataset will not be
able to capture the small proportion of deaths which
occur at home unless they are reported in the registry.
Despite these limitations, this research database will
result in a rich and useful data source. To maximize the
potential of this dataset, ongoing updates of the dataset
will be undertaken by adding incident patients each year
and updating records for existing patients. At this stage,
we have included data only for incident pediatric or young
adult patients with ESRD (age ≤ 21) because this popula-
tion is the focus for our research group; however, the link-
age process could be easily replicated in the future for
incident ESRD patients who are older than 21 years of age.
Conclusions
Combining available national organ failure data with
longitudinal hospitalization records can be a powerful
tool facilitating clinical research among pediatric end-
stage renal disease patients.
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